Research Topics
| T A PearsonSummaryAffiliation: University of Rochester Country: USA Publications
| Collaborators
|
Detail Information
Publications
The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goalsT A Pearson
Department of Community and Preventive Medicine, University of Rochester School of Medicine, NY 14642, USA
Arch Intern Med 160:459-67. 2000....
The undertreatment of LDL-cholesterol: addressing the challengeT A Pearson
Department of Community and Preventive Medicine, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
Int J Cardiol 74:S23-8. 2000..In conclusion, a large proportion of dyslipidemic patients who are being treated in primary care are not achieving NCEP target LDL-C levels...
Translation of nutritional sciences into medical education: the Nutrition Academic Award ProgramT A Pearson
Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Am J Clin Nutr 74:164-70. 2001....
Capacity for research in minority health: the need for infrastructure plus willT A Pearson
Department of Community and Preventive Medicine, University of Rochester School of Medicine, New York, USA
Am J Med Sci 322:243-52. 2001..These additional efforts at the community level should create a fertile environment to develop research and, ultimately, test strategies for reducing national disparities in cardiovascular health...
Capacity for research in minority health: the need for infrastructure plus willT A Pearson
Department of Community and Preventive Medicine, University of Rochester School of Medicine, New York, USA
Am J Med Sci 322:243-7. 2001..These additional efforts at the community level should create a fertile environment to develop research and, ultimately, test strategies for reducing national disparities in cardiovascular health...
Screening family members at high risk for coronary disease. Why isn't it done?J R Swanson
Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14623, USA
Am J Prev Med 20:50-5. 2001..The American College of Cardiology Evaluation of Preventive Therapeutics (ACCEPT) study, a national survey conducted in 1996-1997, determined if physicians were screening first-degree relatives of patients with early CVD...
